Comparison of trastuzumab deruxtecan and sacituzumab govitecan in HER2-negative metastatic breast cancer: a large real-world data analysis.
Saved in:
| Title: | Comparison of trastuzumab deruxtecan and sacituzumab govitecan in HER2-negative metastatic breast cancer: a large real-world data analysis. |
|---|---|
| Authors: | Sledge GWJ; Caris Life Sciences, 4610 S 44th Pl, Phoenix, AZ, 85040, USA. gsledge@carisls.com., Xiu J; Caris Life Sciences, 4610 S 44th Pl, Phoenix, AZ, 85040, USA., Solzak JP; Caris Life Sciences, 4610 S 44th Pl, Phoenix, AZ, 85040, USA., Ribeiro J; Caris Life Sciences, 4610 S 44th Pl, Phoenix, AZ, 85040, USA., Mahtani RL; Baptist Health Miami Cancer Institute, Miami, FL, 33176, USA., Lustberg MB; Yale School of Medicine, New Haven, CT, 06510, USA., Oberley MJ; Caris Life Sciences, 4610 S 44th Pl, Phoenix, AZ, 85040, USA., Radovich M; Caris Life Sciences, 4610 S 44th Pl, Phoenix, AZ, 85040, USA., Spetzler D; Caris Life Sciences, 4610 S 44th Pl, Phoenix, AZ, 85040, USA. |
| Source: | Breast cancer research : BCR [Breast Cancer Res] 2025 Aug 11; Vol. 27 (1), pp. 144. Date of Electronic Publication: 2025 Aug 11. |
| Publication Type: | Journal Article; Comparative Study |
| Journal Info: | Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1465-542X |
|---|---|
| DOI: | 10.1186/s13058-025-02094-7 |
